Infective Endocardiology

Current Problems in Cardiology

Volumn 26, Issue 9, 2001, Pages 560-610

  Mauri, Laura ^a   De Lemos, James A ^a   O'Gara, Patrick T ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFADROXIL; CEFALEXIN; CEFAZOLIN; CEFTRIAXONE; CLARITHROMYCIN; CLINDAMYCIN; GENTAMICIN; NAFCILLIN; OXACILLIN; PENICILLIN G; RIFAMPICIN; VANCOMYCIN;

BACTERIAL ENDOCARDITIS; CLINICAL FEATURE; DISEASE CLASSIFICATION; ENTEROCOCCUS; GRAM POSITIVE BACTERIUM; HEART VALVE SURGERY; HUMAN; INCIDENCE; INTRAVENOUS DRUG ABUSE; MYCOTIC ANEURYSM; PATHOGENESIS; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROPHYLAXIS; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT INDICATION; ECHOCARDIOGRAPHY; ENTEROBACTER INFECTION; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; UNITED STATES;

ECHOCARDIOGRAPHY; ENDOCARDITIS, BACTERIAL; ENTEROBACTERIACEAE INFECTIONS; HUMANS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; UNITED STATES;

EID: 0034770642     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. Infective endocarditis: Clinical spectrum, presentation and outcome. An analysis of 212 cases 1980-1995
2. Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study
3. Infective endocarditis, 1984 through 1993: A clinical and microbiological survey
4. Neurologic manifestations of infective endocarditis: A 17-year experience in a teaching hospital in Finland
5. Neurologic manifestations in Staphylococcus aureus endocarditis: A review of 260 bacteremic cases in nondrug addicts
6. Clinical features of Staphylococcus aureus endocarditis: A 10-year experience in Denmark
7. Early and late survival after surgical treatment of culture-positive active endocarditis
8. Epidemiology of bacterial endocarditis in The Netherlands. I. Patient characteristics
9. Infective endocarditis at a large community teaching hospital, 1980-1990. A review of 210 episodes
10. Systemic hypothermia and circulatory arrest combined with arterial perfusion of the superior vena cava. Effective intraoperative cerebral protection
11. Prosthetic valve endocarditis. Analysis of factors affecting outcome of therapy
12. Infective endocarditis. Olmsted County, Minnesota, 1950 through 1981
13. Results of a prospective statewide reporting system for infective endocarditis
14. Infective endocarditis
15. Incidence and risk factors of prosthetic valve endocarditis
16. Risk factors for the development of prosthetic valve endocarditis
17. Actuarial analysis of the risk of prosthetic valve endocarditis in 1,598 patients with mechanical and bioprosthetic valves
18. Prosthetic valve endocarditis
19. Diagnosis and management of infective endocarditis and its complications
20. Infective endocarditis. An overview
21. Infective endocarditis: Clinical features in young and elderly patients
22. Pneumococcal infections
23. Streptococcal and enterococcal infections
24. Staphylococcal infections
25. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: Experience in 103 patients
26. Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis: A 20-year experience
27. Endocarditis due to Staphylococcus lugdunensis: Report of 11 cases and review
28. Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection
29. Endocarditis and intravascular infections
30. Infections due to pseudomonas species and related organisms
31. Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism
32. Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus
33. Bartonella (Rochalimaea) quintana endocarditis in three homeless men
34. Zoonotic endocarditis
35. Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: A prospective comparative study
36. Endocarditis in intravenous drug users
37. Polymicrobial infective endocarditis in the 1980s
38. Infective endocarditis in intravenous drug users: A comparison of human immunodeficiency virus type 1-negative and -positive patients
39. Culture-negative endocarditis
40. Infective endocarditis with negative blood cultures. An analysis of 52 cases
41. Underlying cardiac lesions in adults with infective endocarditis. The changing spectrum
42. On the relation between the site of valvular involvement in endocarditis and the blood pressure resting on the valve
43. Experimental bacterial endocarditis. 3. Production and progress of the disease in rabbits
44. Transient bacteremia and endocarditis prophylaxis. A review
45. Protective role of complement in experimental Escherichia coli endocarditis
46. Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin
47. Tissue factor is a major stimulus for vegetation formation in enterococcal endocarditis in rabbits
48. Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis
49. Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects
50. Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein
51. Cardiac valve prostheses: Pathological and bioengineering considerations
52. A case for early surgery in native left-sided endocarditis complicated by heart failure: Results in 203 patients
53. Pathoanatomic, pathophysiologic and clinical correlations in endocarditis (second of two parts)
54. Circulating immune complexes in infective endocarditis
55. Diagnostic criteria for identifying cases of endocarditis: Revisiting the Duke criteria two years later
56. Infective endocarditis: A review of 125 cases from the University of Washington Hospitals, 1963-72
57. Infective endocarditis: An analysis based on strict case definitions
58. New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings. Duke Endocarditis Service
59. Evaluation of the Duke criteria versus the Beth Israel criteria for the diagnosis of infective endocarditis
60. Evaluation of new clinical criteria for the diagnosis of infective endocarditis
61. The Duke criteria for diagnosing infective endocarditis are specific: Analysis of 100 patients with acute fever or fever of unknown origin
62. Negative predictive value of the Duke criteria for infective endocarditis
63. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis
64. Infective endocarditis, 1983-1988: Echocardiographic findings and factors influencing morbidity and mortality
65. Transesophageal echocardiography in right-sided endocarditis
66. Echocardiography in infective endocarditis: Reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach
67. Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis
68. Improved detection of infective endocarditis with transesophageal echocardiography
69. Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations
70. Comparison of transthoracic and transesophageal echocardiography for detection of abnormalities of prosthetic and bioprosthetic valves in the mitral and aortic positions
71. Clinical information determines the impact of transesophageal echocardiography on the diagnosis of infective endocarditis by the duke criteria
72. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography
73. Transesophageal echocardiographic recognition of subaortic complications in aortic valve endocarditis. Clinical and surgical implications
74. Echocardiography in patients with suspected endocarditis: A cost-effectiveness analysis
75. Diagnostic value of echocardiography in suspected endocarditis. An evaluation based on the pretest probability of disease
76. Infective endocarditis due to Staphylococcus aureus: 59 Prospectively identified cases with follow-up
77. Emboli in infective endocarditis: The prognostic value of echocardiography
78. Value of transthoracic echocardiography in predicting embolic events in active infective endocarditis. Duke Endocarditis Service
79. Role of transthoracic and transesophageal echocardiography in predicting embolic events in patients with active infective endocarditis involving native cardiac valves
80. Echocardiography predicts embolic events in infective endocarditis
81. Echocardiography predicts embolic events in infective endocarditis
82. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms
83. ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on practice guidelines (Committee on Management of Patients with Valvular Heart Disease)
84. Indications for cardiac surgery in patients with active infective endocarditis
85. Surgical treatment of endocarditis
86. Correlation of echocardiographic and surgical findings in acute bacterial endocarditis
87. Prosthetic valve endocarditis: Clinicopathologic analysis of 22 necropsy patients with comparison observations in 74 necropsy patients with active infective endocarditis involving natural left-sided cardiac valves
88. Endocarditis-associated paravalvular abscesses. Do clinical parameters predict the presence of abscess?
89. Hemorrhagic and ischemic cerebrovascular complications of active infective endocarditis of native valve
90. Valve replacement in patients with endocarditis and acute neurologic deficit
91. Bacterial intracranial aneurysm
92. Can noninvasive imaging accurately depict intracranial aneurysms? A systematic review
93. Relapses, recurrences, valve replacements, and mortality during the long-term follow-up after infective endocarditis
94. Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients
95. Infective endocarditis in patients receiving long-term hemodialysis
96. Prevention of bacterial endocarditis: Recommendations by the American Heart Association
97. Risk factors for infective endocarditis: Oral hygiene and nondental exposures
98. Infective endocarditis in hypertrophic cardiomyopathy: Prevalence, incidence, and indications for antibiotic prophylaxis
99. A controlled evaluation of the risk of bacterial endocarditis in persons with mitral-valve prolapse
100. Mitral valve prolapse and infective endocarditis
101. Identification of high-risk and low-risk subgroups of patients with mitral-valve prolapse
102. Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study
103. Prevention of infective endocarditis
104. Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mitral regurgitant murmur
105. Apparent failures of endocarditis prophylaxis. Analysis of 52 cases submitted to a national registry
106. Treatment of infective endocarditis
107. Assessment of the patient with suspected endocarditis